Search

everythinglearnresearchcommunity

for

Search:↓

Hormonal imbalances in women can cause acne, excess hair growth, and hair loss, needing combined medical and mental health care.

Using 5α-reductase inhibitors for hair loss in women doesn't increase cancer risk.

MESTSV is a rare tumor that is mostly benign but needs long-term monitoring due to potential recurrence.

Testosterone in older women can increase bone density, muscle mass, fat mass, improve memory, and boost libido, but may cause nipple color changes.

Transplant patients often get skin problems, with treatments varying by condition.

A woman was diagnosed with porphyria cutanea tarda and improved with phlebotomy and lifestyle changes.

The document concludes that various skin conditions have specific treatments and that adequate calcium intake may prevent osteoporosis.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Tenofovir is more effective than adefovir for resistant hepatitis B, Fibroscan is good for assessing liver damage, regulatory T cells may help hepatitis C persist, and other insights into liver health and disease were found.

Tranexamic acid effectively reduced swelling episodes in a girl with a rare form of hereditary angioneurotic edema.

Women with a certain type of hair loss have more copper in the back of their head than the front, and treatment can normalize hair but not copper levels.

The more lipophilic the progesterone derivative, the better it binds to androgen receptors and has antiandrogenic effects.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.

Epitestosterone may counteract testosterone's effects and has roles in body processes like prostate growth and hair distribution.

Some synthesized compounds were more effective than Finasteride in reducing prostate cancer cell growth and androgen levels.

New steroids were effective in blocking male hormone receptors in hamster prostates.

Certain derivatives are more effective 5α-reductase type 2 inhibitors than finasteride.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

Applying estradiol to skin causes local changes but not cancer.

Epitestosterone may act as a weak antiandrogen and can inhibit an enzyme involved in testosterone metabolism.

Anabolic steroids and inflammation can disrupt androgen metabolism, potentially causing health issues.

Sex hormones affect brain cells differently in males and females.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

Higher doses of oestradiol implants improve bone density in postmenopausal women.

Certain ESR1 gene variations may affect hormone levels and fat distribution in women with high male hormone levels.

Weak endocrine disruptors in mixtures can have significant effects and should be considered in risk assessments.

DHEA affects various tissues by interacting with multiple receptors and can be converted into sex hormones.

Testosterone and some of its forms can strongly stimulate oil gland growth in skin.